Clinical Trends for January 2017

Ryan Syrek


January 27, 2017

Clinical Trend of the Week (January 14-20): Breast Augmentation

Approval of a new product from the US Food and Drug Administration (FDA) resulted in this week's top search. The FDA approved the Natrelle Inspira SoftTouch (Allergan Plc) breast implant, which is a medium firmness cohesive silicone gel implant. The implants are approved for breast reconstruction, revision surgery to correct or improve previous breast surgery, and breast augmentation. With the winter season a popular time to consider plastic surgery, this new approval helped further drive the popularity of this week's top term.

For more information on breast augmentation, read here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.